Lighthouse Studies at Peer Point
Baltimore, Maryland, 21205, United States
Location status: Recruiting
Location contact
Carl Latkin, PhD
CONTACT
Carl Latkin, PhD
PRINCIPAL_INVESTIGATOR
Melissa Davey-Rothwell, PhD
CONTACT
NCT Number: NCT05320835
A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
Location status: Recruiting
Carl Latkin, PhD
CONTACT
Carl Latkin, PhD
PRINCIPAL_INVESTIGATOR
Melissa Davey-Rothwell, PhD
CONTACT
This is a pilot of an injection setting targeted peer-driven intervention to reduce HIV/HCV transmission and overdose risk behaviors. Participants will be randomized to conditions: 1) Peer education and stocking of semi-public injection settings (SPIS) with risk reduction materials, and the standard of care. Based on their SPIS use, 120 index PWID participants will be selected.
A conceptual model for the intervention: The conceptual model is based on social influence, social network, and social cognitive theory. The prior work delineated social influence mechanisms. It is expected that training and modeling of effective communication skills will increase the occurrence of conversations on HIV/HCV and overdose prevention. These conversations will then alter perceived descriptive and prescriptive social norms of risk behaviors. The prior work is being enhanced by increasing the availability of risk reduction materials as well as the cuing and modeling risk reduction behaviors in risk settings. It has been found that PWID are motivated to conduct peer education; it enhances their status and provides them a prosocial role in the community. It is hypothesized that peer outreach and supply of materials to SPIS will lead to reduced sharing of injection equipment and increased naloxone availability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HIV, HCV and overdose prevention
Time frame: 6 months
Frequency of carrying naloxone
Time frame: 6 months
Frequency of using used cookers
Time frame: 6 months
Frequency of testing drugs before using
Time frame: 6 months
Frequency of talking about overdose prevention
Contact information is provided by the study sponsor or research team.
Carl Latkin, PhD
CONTACT
Lauren Dayton, PhD
CONTACT
Johns Hopkins Bloomberg School of Public Health
Other
A Geospatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs in Baltimore, Maryland
Acronym: Oasis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06316739
Blood-Borne Infections, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT07429864
Adenocarcinoma, Bile Acid Malabsorption
Roma, Italy
View Trial DetailsNCT05343169
Blood-Borne Infections, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05977881
Behavior, Blood-Borne Infections
Baltimore, Maryland, United States
View Trial Details